Litton Bionetics
Executive Summary
Litton Industries announced it is selling the remaining 25% of its biotech unit to Hazeiton Labs. Firm previously sold about half of the business to Akzo Pharma subsidiary Organon Teknika and about 25% to MetPath, Inc., a subsidiary of Corning Glass Works.